All News

This medication inhaler is indicated for the treatment or prevention of bronchospasm in patients ages 4 years and older who have reversible obstructive airway disease.

The antiviral drug remdesivir was originally developed as a treatment for Ebola in 2014, but upon the surge of COVID-19, its use was investigated in treating COVID-19.

Michael Klepser, PharmD, FCCP, FIDP is not only a part of this group, but was also a potential carrier of the virus himself.

In response to the financial crisis driven by the coronavirus disease 2019 (COVID-19) pandemic, drug manufacturers are aiming to increase access to insulin products.

More than one-third of transgender women (TGW) not living with HIV at baseline were indicated for pre-exposure prophylaxis (PrEP).

US Department of Health and Human Services (HHS) Secretary Alex Azar released a statement on how the authorization for pharmacists will mean easier access for patients who need COVID-19 testing.

Today we’re celebrating Lendi Muehlbauer, RPh, who works at a Rite Aid in New Jersey.

The FDA has approved encorafenib in combination with cetuximab for the treatment of adult patients with metastatic colorectal cancer with a BRAF V600E mutation after prior therapy.

With all the factors of the COVID-19 outbreak taken into consideration, simply maintaining your current body weight and level of health and fitness is a win worth celebrating.

Owen Mumford, Inc is working with GEMA to donate 500,000 Unistik safety lancets and 5,000 Peezy urine specimen collection kits.

Access to OmniSYS Training Center supports pharmacists as front-line responders.

Coronaviruses are known to utilize the ACE2 to help facilitate entry into the host target cell.

In this episode of OnScript with NHA, Jeremy Sasser and Jessica Langley talk with Rick Richey, master instructor for the National Academy of Sports Medicine.

ASHP’s 2020 Residency Match concluded with 5269 individuals matching with 2551 pharmacy residency programs across the country.

Understanding patients' perspectives help engender their trust and loyalty, and affect positively their treatment outcomes and the pharmacy business.

PittCoVacc produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing COVID-19 within 2 weeks.

Today, we’re thanking Lusine Khachatryan, PharmD, RPh, a staff pharmacist at Vons Pharmacy in Tujunga, California.

As investigators continue to study the use of drugs such as remdesivir for the treatment of the COVID-19 pandemic, some researchers are considering drug repurposing as a temporary solution.

We asked international pharmacists to share what they’re experiencing on the frontlines of the COVID-19 outbreak in their countries.

Cervical cancer screening rates in Japan were significantly affected in the years following the devastating Great East Japan Earthquake of 2011, suggesting that disasters can affect cervical cancer screening for years.

Adult patients with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin in a wearable, patch-like insulin delivery device called V-Go.

The American Society of Health-System Pharmacists (ASHP) is surveying members of the Section of Pharmacy Practice leaders on a bi-weekly basis to obtain the real-time status of medical supplies during the coronavirus disease 2019 (COVID-19) pandemic.

During this period, 1834 participants developed lung cancer, of whom 290 had COPD and 1544 did not, according to the researchers.

Directions in Pharmacy® is a full-day regional conference for community and health-system pharmacists.

The states included are Arizona, Florida, Illinois, Kentucky, Louisiana, Tennessee, and Texas.

Our chief pharmacy editor, Troy Trygstad, PharmD, MBA, PhD, discusses various challenges and opportunities for pharmacists in rural areas during the COVID-19 pandemic.

Shivam Patel, PharmD, discusses one way pharmacist roles are changing during the COVID-19 pandemic.

Experts in Idaho are hoping that the state’s broad practice laws for pharmacists and technicians will provide a blueprint for other states looking to expand pharmacists’ capabilities.